Dr. Tianxu Xia is a board-certified, fellowship-trained behavioral neurologist and neuropsychiatrist. His clinical interests include various neurodegenerative diseases, such as Alzheimer’s disease, Lewy body disease, frontotemporal dementia, primary progressive aphasia, corticobasal syndrome, and progressive supranuclear palsy, among others. He is also focused on the management of neuropsychiatric symptoms associated with different cognitive and behavioral disorders.
Dr. Xia received his medical degree at Harbin Medical University in Heilongjiang, China. He completed general adult psychiatry residency training at Maimonides Medical Center in Brooklyn, New York, with enfolded training in psycho-oncology and consultation-liaison psychiatry at Memorial Sloan Kettering Cancer Center. He went on to complete fellowship training in behavioral neurology and neuropsychiatry at Yale University School of Medicine in New Haven, Connecticut. He joined the faculty at McGovern Medical School at UTHealth Houston in 2025 after serving as an assistant professor of neurology and psychiatry at the Icahn School of Medicine at Mount Sinai in New York City, where he was assistant director of neurobehavioral education and co-director of the behavioral neurology and neuropsychiatry fellowship training program.
Xia T, Li C, Iverson A, Spat-Lemus J, Woroch A, Naasan G. Behavioral variant frontotemporal dementia with pathogenic variant in MAPT presenting as dementia with Lewy body disease. Neurocase. 2025 Feb;31(1):23-28. doi: 10.1080/13554794.2024.2440548. Epub 2024 Dec 10. PMID: 39658879; PMCID: PMC12082706.
Virani S, Xia T, Brainch N, Mitra S, Ahmed S, Mutasiigwa H, Chaudhari G, Zaveri D. Scaling the great wall: The impact of communication barriers on quality of psychiatric care in Chinese patients. Int J Soc Psychiatry. 2020 Mar;66(2):150-155. doi: 10.1177/0020764019888959. Epub 2019 Dec 2. PMID: 31789574.
Mahgoub Y, Madden K, Xia T. When Green Becomes Mean: Green Tea Extract Reduces Ziprasidone’s Effect and Causes Psychosis. Prim Care Companion CNS Disord. 2020 Jan 23;22(1):19l02487. doi: 10.4088/PCC.19l02487. PMID: 31995673.